Southeast Gynecologic Oncology Associates
Jacksonville, Florida, United States
Oncologist in Jacksonville, Florida
915 W Monroe St #300, Jacksonville, FL 32204
About Southeast Gynecologic Oncology Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gynecologic Oncology Group
2
National Cancer Institute (NCI)
2
GOG Foundation
1
Clinical Trials at Southeast Gynecologic Oncology Associates
During the past decade, Southeast Gynecologic Oncology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
2005-03-21
2022-02-22
Active, not recruiting
1,157
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
2009-03-23
Unknown status
601
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
2009-06-29
2024-07-28
Active, not recruiting
813
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
2009-08-11
2016-01-11
Completed
1,560
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
2010-09-27
2023-06-07
Active, not recruiting
692
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Southeast Gynecologic Oncology Associates"
#1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Southeast Gynecologic Oncology Associates
According to Clinical.Site data, the most researched conditions in "Southeast Gynecologic Oncology Associates" are
"Fallopian Tube Endometrioid Adenocarcinoma" (3 trials), "Fallopian Tube Mucinous Adenocarcinoma" (3 trials), "Fallopian Tube Transitional Cell Carcinoma" (3 trials), "Ovarian Endometrioid Adenocarcinoma" (3 trials) and "Ovarian Mucinous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Southeast Gynecologic Oncology Associates" in a lesser frequency.
Clinical Trials Intervention Types at Southeast Gynecologic Oncology Associates
Most popular intervention types in "Southeast Gynecologic Oncology Associates" are "Drug" (5 trials), "Other" (4 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Quality-of-Life Assessment" (4 trials), "Laboratory Biomarker Analysis" (3 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Southeast Gynecologic Oncology Associates
The vast majority of trials in "Southeast Gynecologic Oncology Associates" are
5 trials for "Female" genders.
Clinical Trials Status at Southeast Gynecologic Oncology Associates
Currently, there are NaN active trials in "Southeast Gynecologic Oncology Associates".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Southeast Gynecologic Oncology Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Southeast Gynecologic Oncology Associates, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".